Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Pharmacogenetics of bipolar disorder.

Mansour HA, Alda M, Nimgaonkar VL.

Curr Psychiatry Rep. 2002 Apr;4(2):117-23. Review.

PMID:
11914172
2.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
3.

Serotonin transporter linked promoter (polymorphism) in the serotonin transporter gene may be associated with antidepressant-induced mania in bipolar disorder.

Masoliver E, Menoyo A, Pérez V, Volpini V, Rio ED, Pérez J, Alvarez E, Baiget M.

Psychiatr Genet. 2006 Feb;16(1):25-9.

PMID:
16395126
4.

Pharmacogenetics and bipolar disorder.

Mamdani F, Groisman IJ, Alda M, Turecki G.

Pharmacogenomics J. 2004;4(3):161-70. Review.

PMID:
15079146
5.

Genetic factors and treatment of mood disorders.

Alda M.

Bipolar Disord. 2001 Dec;3(6):318-24. Review.

PMID:
11843781
6.

[Predictors of prophylactic response to lithium].

Rohayem J, Baylé JF, Richa S.

Encephale. 2008 Sep;34(4):394-9. doi: 10.1016/j.encep.2007.05.002. Epub 2007 Nov 26. Review. French.

PMID:
18922242
7.

Association studies of 5-HT2A and 5-HT2C serotonin receptor gene polymorphisms with prophylactic lithium response in bipolar patients.

Dmitrzak-Weglarz M, Rybakowski JK, Suwalska A, Słopień A, Czerski PM, Leszczyńska-Rodziewicz A, Hauser J.

Pharmacol Rep. 2005 Nov-Dec;57(6):761-5.

8.
9.

Pharmacogenetics of lithium response in bipolar disorder.

Alda M.

J Psychiatry Neurosci. 1999 Mar;24(2):154-8. Review.

10.

Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype.

Rybakowski JK, Suwalska A, Czerski PM, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J.

Pharmacol Rep. 2005 Jan-Feb;57(1):124-7.

11.

Treatments for late-life bipolar disorder.

Aziz R, Lorberg B, Tampi RR.

Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. Review.

PMID:
17296540
12.

Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder.

Washizuka S, Ikeda A, Kato N, Kato T.

Int J Neuropsychopharmacol. 2003 Dec;6(4):421-4.

PMID:
14604458
13.

Predicting response to lithium in bipolar disorder: a critical review of pharmacogenetic studies.

Smith DJ, Evans R, Craddock N.

J Ment Health. 2010 Apr;19(2):142-56. doi: 10.3109/09638230903469103. Review.

PMID:
20433322
14.

Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.

Mamdani F, Jaitovich Groisman I, Alda M, Turecki G.

Curr Psychiatry Rep. 2003 Dec;5(6):484-92. Review.

PMID:
14609504
15.

Pharmacogenetics and mood stabilization in bipolar disorder.

Ruzickova M, Turecki G, Alda M.

Am J Med Genet C Semin Med Genet. 2003 Nov 15;123C(1):18-25. Review.

PMID:
14601033
16.

The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder.

Ferreira Ade A, Neves FS, da Rocha FF, Silva GS, Romano-Silva MA, Miranda DM, De Marco L, Correa H.

J Affect Disord. 2009 Jan;112(1-3):267-72. doi: 10.1016/j.jad.2008.04.012. Epub 2008 Jun 4.

PMID:
18534687
17.

The role of pharmacogenetics in the treatment of depression and anxiety disorders.

Schosser A, Kasper S.

Int Clin Psychopharmacol. 2009 Nov;24(6):277-88. doi: 10.1097/YIC.0b013e3283306a2f. Review.

PMID:
19738481
18.

Genetic predictors of response to antidepressants in the GENDEP project.

Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O, Hauser J, Maier W, Kozel D, Henigsberg N, Barreto M, Placentino A, Dernovsek MZ, Schulze TG, Kalember P, Zobel A, Czerski PM, Larsen ER, Souery D, Giovannini C, Gray JM, Lewis CM, Farmer A, Aitchison KJ, McGuffin P, Craig I.

Pharmacogenomics J. 2009 Aug;9(4):225-33. doi: 10.1038/tpj.2009.12. Epub 2009 Apr 14.

PMID:
19365399
19.

Eating disorders, serotonin transporter polymorphisms and potential treatment response.

Gorwood P.

Am J Pharmacogenomics. 2004;4(1):9-17. Review.

PMID:
14987118
20.

The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.

Serretti A, Benedetti F, Zanardi R, Smeraldi E.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):1074-84. Review.

PMID:
15939518
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk